Assessing the human gut microbiota in metabolic diseases - Test2 - elhamkhani - TriplyDB

Assessing the human gut microbiota in metabolic diseases

Assessing the human gut microbiota in metabolic diseases

http://www.wikidata.org/entity/Q26860785

about

Gut Microbiota and Lifestyle Interventions in NAFLD The obese gut microbiome across the epidemiologic transition Synthetic Ecology of Microbes: Mathematical Models and Applications Role of the normal gut microbiota Metagenomic surveys of gut microbiota Beneficial Microbes: The pharmacy in the gut Exploring Relationships between Host Genome and Microbiome: New Insights from Genome-Wide Association Studies New insights into therapeutic strategies for gut microbiota modulation in inflammatory diseases From next-generation sequencing to systematic modeling of the gut microbiome Gut bacterial diversity of the tribes of India and comparison with the worldwide data.Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort.AMP-activated Protein Kinase (AMPK): Does This Master Regulator of Cellular Energy State Distinguish Insulin Sensitive from Insulin Resistant Obesity?Microbial translocation and cardiometabolic risk factors in HIV infection.Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen.Dietary effects on resting metabolic rate in C57BL/6 mice are differentially detected by indirect (O2/CO2 respirometry) and direct calorimetry.Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options.Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.Microbial 'old friends', immunoregulation and socioeconomic status.Long term follow up of celiac disease-is atherosclerosis a problem?Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approaches Microbiota and diabetes: an evolving relationship.Diet-induced extinctions in the gut microbiota compound over generations.The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists.Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet Mechanisms underlying weight loss and metabolic improvements in rodent models of bariatric surgery.Modulation of gut microbiota in the management of metabolic disorders: the prospects and challenges Beneficial modulation of the gut microbiota.The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity The microbiota, the immune system and the allograft.Conducting a microbiome study.Symbiosis, dysbiosis, and rebiosis-the value of metaproteomics in human microbiome monitoring.Biomarkers of insulin sensitivity and insulin resistance: Past, present and future.Non-alcoholic fatty liver disease, diet and gut microbiota.Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples.In silico identification of bacteriocin gene clusters in the gastrointestinal tract, based on the Human Microbiome Project's reference genome database Effect of Whole-Grain Barley on the Human Fecal Microbiota and Metabolome.Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol The Gut Microbiota Reduces Colonization of the Mesenteric Lymph Nodes and IL-12-Independent IFN-γ Production During Salmonella Infection Novel Agents for the Treatment of Type 2 Diabetes.The features of mucosa-associated microbiota in primary sclerosing cholangitis

P2860

Q26749783-19FEAFFB-0BA0-4D26-9E40-B73C3735D38F Q26772183-691EF82D-752D-4D72-A50C-E9B722A5913B Q26777567-30B157E8-07D4-4BB9-AA8F-9BD00BF78ACF Q26798294-CE6E3401-6881-42BE-9A94-F24D9C0D4171 Q26799820-66F765CD-CB3E-4E2A-8C67-DDD054482A8C Q28067936-076741E0-FA60-4B4F-9944-6326CD064734 Q28077937-02984AAE-45F4-4213-9B8E-BC862F752709 Q28079638-60140AED-BEF2-49F6-8C81-2C1B62F05702 Q28082185-DA15195B-494F-48FD-807A-67F6ACCB6368 Q30386497-A61A6203-46C8-4881-A52A-CBD12BECF47C Q33560362-51D801B2-9730-44B0-936E-320F2F808587 Q33688657-5688DBCC-071F-42F8-99A9-B6ED469453EF Q33713895-33925A9D-5283-46A2-9779-CA845AA420DD Q33724931-4B4E9BE8-52C5-4F7E-A6B5-F0178FD48011 Q33765647-E96B5F03-1466-4DAA-8134-CB13BBBA1510 Q33805285-36791227-B833-4F72-A00A-6E833EB650B8 Q33838229-03367F96-1049-416C-8A12-61B1A172DC65 Q33871387-E7EF0855-F0C1-41C3-BAA2-CF16BCB71707 Q33963298-ECAA5522-91AB-435B-AC05-6194086AC9A1 Q34114026-B2CDF6CB-08AC-418E-BB0F-77521692ACA9 Q34420231-ECC2D0BE-F15E-4700-8E88-2383A5F67393 Q34508832-D995F230-114A-4295-81AC-B2E5D40C21BA Q34553267-1C50AFB0-F30D-4DC6-92C8-A91B0073646C Q34677228-BB05424F-5145-41B1-9267-C1017AAC45BD Q34898952-1FB84089-011C-4C6A-868A-133AE5F536A6 Q35114851-F775E4A8-9404-41AD-B9F7-83C4A6E1E9A2 Q35134825-06F31F46-99CC-46C4-8B0E-F06B07950106 Q35142299-63C104AB-AC93-488D-AD54-BEA0FB06BA2B Q35170799-1DA16832-526D-4A72-A749-3198902CD7D8 Q35208886-1C189D58-74C2-4141-A398-902A67CB0C9B Q35328312-A4081BEC-E1E0-4C16-A9DC-5D898B9CE498 Q35652813-79FB39A3-8220-4CEA-A522-BFFC1F8D09BE Q35728214-28C501FA-30B0-4C8D-B84C-5E5604F3A398 Q35728959-7ADAF472-12C7-4EC0-93CD-D705139A0EC3 Q35777738-0304ECE0-1E58-426C-AD86-89EDCC275F18 Q35781152-74138984-6F49-4317-AE92-9E9F04E17555 Q35860576-18630FF1-C5DB-4680-A9D6-57B67E434FC6 Q35886436-45975754-451A-40AA-B044-58A88EE1D95B Q35910421-EACA237F-4FA9-46CA-BD3A-3EF95CEFA21F Q35917819-0A07354E-DEBD-4311-942D-2A542D0F7D65

P2860

Assessing the human gut microbiota in metabolic diseases

http://www.wikidata.org/entity/Q26860785

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Assessing the human gut microbiota in metabolic diseases

@ast

Assessing the human gut microbiota in metabolic diseases

@en

Assessing the human gut microbiota in metabolic diseases

@nl

type

label

Assessing the human gut microbiota in metabolic diseases

@ast

Assessing the human gut microbiota in metabolic diseases

@en

Assessing the human gut microbiota in metabolic diseases

@nl

prefLabel

Assessing the human gut microbiota in metabolic diseases

@ast

Assessing the human gut microbiota in metabolic diseases

@en

Assessing the human gut microbiota in metabolic diseases

@nl

P1433

Q26860785-E31235B7-F1C6-47FE-946A-F93B0E12AE7B

P1476

Q26860785-BAB6F0F0-4D4F-4081-A078-4691D50249A8

P275

Q26860785-A4D3F75F-40A0-4E8A-873E-7CA85AAFCC24

P2860

Q26860785-00476194-7E4A-4FA6-A280-8E77D8584829

Q26860785-02FEE951-0CC3-458B-B69A-947776DDD433

Q26860785-04C4D905-DF58-4E73-BFBF-1AC036D64A22

Q26860785-0B6FC30E-9255-472C-97D2-605F2C8565CB

Q26860785-100B85F6-094B-44BC-A561-53C532C5D123

Q26860785-1184BCB3-55BB-4D1A-9B89-0299B85B8F14

Q26860785-142B99C6-4DA2-4489-A0D2-3E3242066834

Q26860785-151340D6-1B27-45E4-A4BA-45B7567DBF31

Q26860785-17D21D33-71BD-4A1F-B769-984084529B0A

Q26860785-1C39619D-3EBA-4AF1-869D-48E3EDC30B52

P304

Q26860785-9E3944AB-AFF7-4FBE-A2D9-755312B27688

P31

Q26860785-46A3A6FF-5EE3-4597-9D1B-8A724CD8EB0D

Q26860785-6D1D2EA9-6F55-4802-BEE8-1A3FB43ECF48

P3181

Q26860785-99F6D426-8C5F-4A81-9261-1C74EC72A88F

P356

Q26860785-7E14F891-6783-4040-9996-E42D594BF6AD

P407

Q26860785-4F4FA1D6-2707-4721-B11E-EF20018381DC

P433

Q26860785-F3115E69-EBE3-4A9D-8301-C934844D90B2

P478

Q26860785-B04625B2-A5CB-49A5-8B53-AA3149AEAC00

P50

Q26860785-045A11E3-8DF4-4DEF-9870-99DABC09893D

Q26860785-180D6DAF-2041-4F0F-9F81-20D378E5BDB0

Q26860785-82A1488F-8A92-45B6-9871-B4764DFA7E9D

Q26860785-E2009AB7-541E-4C8D-B22D-499775D89FB6

P5008

Q26860785-7FDB67D5-B803-4A62-A693-D99A595B18A5

P577

Q26860785-4852CBAF-F4E4-4CCC-ACCC-A6BF7E3619EC

Q26860785-7957102C-E110-4998-B5A6-462EACB9BD79

P5875

Q26860785-272FF35E-3E09-40B5-8B75-7045421A9887

P698

Q26860785-1B6601E5-25DD-4237-9278-9E0545AAC0C9

P921

Q26860785-1C71B68A-62AC-4F8A-9C62-0DAF77F2A2BB

Q26860785-4C6ED6E6-D599-4548-BA2B-447E20121546

Q26860785-55357D66-11D8-49C1-B19E-0A20663B7BAD

Q26860785-8B9B6ED0-B3BC-44AB-9B8B-75087244E3A3

Q26860785-9CFE3F23-7E25-413A-A006-08E3B6C434E1

Q26860785-C370883F-2DF2-43A1-A557-433D14DBCEC6

Q26860785-C6EAE2FE-FF1B-4D1E-9E9D-A8481C36E16C

Q26860785-D06AE16A-F100-4A5C-A7A1-2A6488012877

Q26860785-DDFE51EC-5A40-4B83-82A0-844C9CAE8861

P932

Q26860785-680C0677-EEAC-4274-AC4E-98A31FC903A6

P3181

P356

P1433

P1476

Assessing the human gut microbiota in metabolic diseases

@en

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

Metabolic reconstruction for metagenomic data and its application to the human microbiome

CAMERA: a community resource for metagenomics

The metagenomics RAST server - a public resource for the automatic phylogenetic and functional analysis of metagenomes

The COG database: an updated version includes eukaryotes

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

SmashCommunity: a metagenomic annotation and analysis tool

Obesity alters gut microbial ecology

Diversity of the human intestinal microbial flora

The gut flora as a forgotten organ

Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases

P304

3341-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1380640

http://www.w3.org/2001/XMLSchema#string

P356

10.2337/DB13-0844

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Fredrik Bäckhed

Fredrik Karlsson

Valentina Tremaroli

P5008

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257072074

http://www.w3.org/2001/XMLSchema#string

P698

24065795

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

type-1 diabetes

type-2 diabetes

maturity-onset diabetes of the young

physiological phenomena

P932

3781439

http://www.w3.org/2001/XMLSchema#string